BlackRock’s Champions Oncology CSBR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$891K Buy
120,829
+4,970
+4% +$36.6K ﹤0.01% 4218
2025
Q1
$1.01M Sell
115,859
-441
-0.4% -$3.83K ﹤0.01% 4140
2024
Q4
$997K Buy
116,300
+109
+0.1% +$934 ﹤0.01% 4166
2024
Q3
$566K Buy
116,191
+119
+0.1% +$580 ﹤0.01% 4244
2024
Q2
$600K Buy
116,072
+389
+0.3% +$2.01K ﹤0.01% 4246
2024
Q1
$567K Sell
115,683
-414
-0.4% -$2.03K ﹤0.01% 4280
2023
Q4
$652K Sell
116,097
-200
-0.2% -$1.12K ﹤0.01% 4286
2023
Q3
$722K Sell
116,297
-842
-0.7% -$5.23K ﹤0.01% 4265
2023
Q2
$747K Buy
117,139
+1,292
+1% +$8.24K ﹤0.01% 4283
2023
Q1
$466K Sell
115,847
-6,211
-5% -$25K ﹤0.01% 4460
2022
Q4
$550K Sell
122,058
-78
-0.1% -$352 ﹤0.01% 4500
2022
Q3
$916K Sell
122,136
-1,223
-1% -$9.17K ﹤0.01% 4419
2022
Q2
$988K Buy
123,359
+561
+0.5% +$4.49K ﹤0.01% 4449
2022
Q1
$999K Sell
122,798
-648
-0.5% -$5.27K ﹤0.01% 4577
2021
Q4
$1.03M Buy
123,446
+1,048
+0.9% +$8.75K ﹤0.01% 4585
2021
Q3
$1.25M Buy
122,398
+15,376
+14% +$157K ﹤0.01% 4434
2021
Q2
$1.1M Sell
107,022
-363,425
-77% -$3.74M ﹤0.01% 4417
2021
Q1
$5.32M Buy
470,447
+4,988
+1% +$56.4K ﹤0.01% 3858
2020
Q4
$5.02M Buy
465,459
+15,447
+3% +$167K ﹤0.01% 3635
2020
Q3
$4.16M Buy
450,012
+14,384
+3% +$133K ﹤0.01% 3554
2020
Q2
$4.17M Buy
435,628
+287,677
+194% +$2.75M ﹤0.01% 3525
2020
Q1
$1.1M Buy
147,951
+6,374
+5% +$47.2K ﹤0.01% 3767
2019
Q4
$1.18M Buy
141,577
+4,214
+3% +$35.1K ﹤0.01% 3895
2019
Q3
$776K Buy
137,363
+336
+0.2% +$1.9K ﹤0.01% 4012
2019
Q2
$1.07M Buy
137,027
+14,733
+12% +$115K ﹤0.01% 3928
2019
Q1
$1.2M Sell
122,294
-2,717
-2% -$26.6K ﹤0.01% 3810
2018
Q4
$976K Buy
125,011
+1,471
+1% +$11.5K ﹤0.01% 3854
2018
Q3
$2.16M Buy
123,540
+107,202
+656% +$1.87M ﹤0.01% 3699
2018
Q2
$104K Buy
+16,338
New +$104K ﹤0.01% 4402